High prevalence and risk factors for osteoporosis in 1839 patients with systemic sclerosis: a systematic review and meta-analysis

[1] Denton CP(2017)Systemic sclerosis Lancet (London, England) 390 1685-1699

[2] Khanna D(2019)Pathophysiology of systemic sclerosis: current understanding and new insights Expert Rev Clin Immunol 15 753-764

[3] Cutolo M(2008)Musculoskeletal involvement in systemic sclerosis Best Pract Res Clin Rheumatol 22 339-350

[4] Soldano S(2017)Musculoskeletal involvement in systemic sclerosis: an unexplored aspect of the disease J Scleroderma Relat Disord 2 19-32

[5] Smith V(2014)The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope Am J Med Sci 347 54-63

[6] Randone SB(2005)Prognostic factors of low bone mineral density in systemic sclerosis Clin Exp Rheumatol 23 180-184

[7] Guiducci S(2013)Low bone density in systemic sclerosis A systematic review J Rheumatol 40 1881-1890

[8] Cerinic MM(2014)Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries Clin Rheumatol 33 153-164

[9] Varju C(2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ (Clin Res Ed) 339 b2700-10

[10] Pentek M(2015)The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review J Evid Based Med 8 2-560

[1] Denton CP(2017)Systemic sclerosis Lancet (London, England) 390 1685-1699

[2] Khanna D(2019)Pathophysiology of systemic sclerosis: current understanding and new insights Expert Rev Clin Immunol 15 753-764

[3] Cutolo M(2008)Musculoskeletal involvement in systemic sclerosis Best Pract Res Clin Rheumatol 22 339-350

[4] Soldano S(2017)Musculoskeletal involvement in systemic sclerosis: an unexplored aspect of the disease J Scleroderma Relat Disord 2 19-32

[5] Smith V(2014)The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope Am J Med Sci 347 54-63

[6] Randone SB(2005)Prognostic factors of low bone mineral density in systemic sclerosis Clin Exp Rheumatol 23 180-184

[7] Guiducci S(2013)Low bone density in systemic sclerosis A systematic review J Rheumatol 40 1881-1890

[8] Cerinic MM(2014)Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries Clin Rheumatol 33 153-164

[9] Varju C(2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ (Clin Res Ed) 339 b2700-10

[10] Pentek M(2015)The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review J Evid Based Med 8 2-560